Shanghai Shyndec Pharmaceutical Co., Ltd. Class ASSE: 600420

Announcement on Progress in Accepting Drug Marketing Authorization by Holding Subsidiary

· Issued by Shanghai Shyndec Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Progress in Accepting Drug Marketing Authorization by Holding Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment